COVID-19 in rheumatic disease patients on immunosuppressive agents
Saika Sharmeen, Ahmed Aly Elghawy, Fnu Zarlasht, Qingping Yao
Topics & Concepts
MedicineTocilizumabHydroxychloroquineRituximabInternal medicinePneumoniaSecukinumabExacerbationRheumatoid arthritisMechanical ventilationRitonavirDiseaseImmunologyCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)Viral loadVirusPsoriatic arthritisAntiretroviral therapyLymphomaAutoimmune and Inflammatory Disorders ResearchCOVID-19 Clinical Research StudiesDermatological and COVID-19 studies